Dewpoint receives FDA orphan drug designation for DPTX3186
Dewpoint Receives FDA Orphan Drug Designation Dewpoint Therapeutics has received the US FDA's Orphan Drug Designation (ODD) for DPTX3186, a small-molecule condensate modulator for treating…
Dewpoint Receives FDA Orphan Drug Designation Dewpoint Therapeutics has received the US FDA's Orphan Drug Designation (ODD) for DPTX3186, a small-molecule condensate modulator for treating…
Abu Dhabi to Develop Regulatory Framework for Novel Foods ADAFSA has partnered with the Abu Dhabi Quality and Conformity Council (QCC) and…
Nathan McSweeney Back in Form for South Australia Nathan McSweeney has scored his first Sheffield Shield century for South Australia, givi…
Launch of Public Consultation on Gang-Related Offending The Crown Prosecution Service is seeking views on the prosecution of 'gang'-based …
Cumbria Firm Wins National Healthcare Award An Eden-based business, CCL Solutions, has been named Consultancy of the Year at the National …
Wizz Air and Ryanair Expand Operations in Cyprus Cyprus solidifies its position as a year-round destination with Wizz Air and Ryanair intr…
Spot the Anglican Irony - THE OTHER CHEEK Ridley Melbourne’s Michael Bird asks in the wake of the Gafcon announcement of the Global Anglic…
Broad Survival Benefit from MATTERHORN Trial The MATTERHORN trial's results show a new approach to biomarker use, potentially expanding ac…
Hong Kong Tennis Open: Last China Players Exit Zhang Shuai and Wang Yafan lost in straight sets, while top seed Belinda Bencic continued h…
Kerala to Eradicate Extreme Poverty According to Minister MB Rajesh, Kerala is set to become the first Indian state to eradicate extreme p…
The Coming Dementia Crisis—and the Cost of Doing Nothing Joel Salinas, founder and chief medical officer of Isaac Health, examines the gro…